However, this is an interesting topic because patients with ALS are characterized by muscle damage, and FNDC5/irisin, known for its anabolic action on skeletal muscle, could represent a biomarker of muscle damage in neurodegenerative diseases (Figure 2). The gene discussed is FNDC5; the disease is neurodegenerative disease.